Видео ютуба по тегу Nikhil C. Munshi

Dr. Nikhil Munshi discusses progress in multiple myeloma treatment
Dr. Nikhil Munshi discusses progress in multiple myeloma treatment
Nikhil C. Munshi, MD, on how physicians should sequence therapies in untreated MM patients
Nikhil C. Munshi, MD, on how physicians should sequence therapies in untreated MM patients
Nikhil C. Munshi, MD, discusses the exciting news at ASH multiple myeloma patients
Nikhil C. Munshi, MD, discusses the exciting news at ASH multiple myeloma patients
Nikhil C. Munshi, MD, discusses his optimism about the use of immunotherapies to treat MM patients
Nikhil C. Munshi, MD, discusses his optimism about the use of immunotherapies to treat MM patients
Nikhil C. Munshi, MD, on whether we can start to associate the word “cure” with MM patients
Nikhil C. Munshi, MD, on whether we can start to associate the word “cure” with MM patients
Patient Seminar with Prof. Nikhil C. Munshi: Minimal residual disease in Myeloma Session 1
Patient Seminar with Prof. Nikhil C. Munshi: Minimal residual disease in Myeloma Session 1
Dr. Munshi Discusses Multiple Myeloma Treatment Sequencing and Selection
Dr. Munshi Discusses Multiple Myeloma Treatment Sequencing and Selection
Insights into the genomics of multiple myeloma - new drug targets and when to do a genomic analysis
Insights into the genomics of multiple myeloma - new drug targets and when to do a genomic analysis
Nikhil Munshi | ASH 2018 | Biological significance of non-coding mutations in multiple myeloma
Nikhil Munshi | ASH 2018 | Biological significance of non-coding mutations in multiple myeloma
Using MRD to guide MM treatment
Using MRD to guide MM treatment
BCMA Loss During Multiple Myeloma Therapy, with Dr. Munshi
BCMA Loss During Multiple Myeloma Therapy, with Dr. Munshi
Dr. Munshi on the Role of Checkpoint Inhibitors in Myeloma
Dr. Munshi on the Role of Checkpoint Inhibitors in Myeloma
Nikhil Munshi, MD, on the association between MRD and survival outcomes in multiple myeloma
Nikhil Munshi, MD, on the association between MRD and survival outcomes in multiple myeloma
MRD techniques and their impact | Nikhil Munshi, USA
MRD techniques and their impact | Nikhil Munshi, USA
What impact have new minimal residual disease (MRD) assessment techniques had in myeloma?
What impact have new minimal residual disease (MRD) assessment techniques had in myeloma?
Novel avenues for MM treatment: CAR T-cells, venetoclax, induction & MRD
Novel avenues for MM treatment: CAR T-cells, venetoclax, induction & MRD
Analysis from Experts|Pro. Nikhil Munshi: Application and In-depth Analysis of BCMA-CART in MM
Analysis from Experts|Pro. Nikhil Munshi: Application and In-depth Analysis of BCMA-CART in MM